Glassman Wealth Services Incyte Corp Transaction History

Glassman Wealth Services

$585 Million
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$52.16 - $64.19 $521 - $641	-10 Reduced 2.3%	425 $26,000
Q3 2023 Nov 13, 2023	SELL	$57.77 - $65.93 $11,842 - $13,515	-205 Reduced 32.03%	435 $25,000
Q2 2023 Aug 08, 2023	BUY	$60.95 - $75.51 $12,982 - $16,083	213 Added 49.88%	640 $39,000
Q1 2023 May 04, 2023	BUY	$70.23 - $86.01 $351 - $430	5 Added 1.18%	427 $30,000
Q4 2022 Feb 06, 2023	SELL	$67.18 - $84.11 $537 - $672	-8 Reduced 1.86%	422 $33,000
Q3 2022 Nov 09, 2022	SELL	$66.18 - $82.86 $661 - $828	-10 Reduced 2.27%	430 $29,000
Q2 2022 Aug 04, 2022	SELL	$66.18 - $83.18 $2,117 - $2,661	-32 Reduced 6.78%	440 $33,000
Q1 2022 Aug 23, 2022	BUY	$66.02 - $79.71 $330 - $398	5 Added 1.07%	472 $37,000
Q1 2022 Apr 14, 2022	SELL	$66.02 - $79.71 $2,310 - $2,789	-35 Reduced 6.97%	467 $37,000
Q4 2021 Feb 14, 2022	BUY	$63.34 - $74.11 $10,894 - $12,746	172 Added 52.12%	502 $37,000
Q3 2021 Nov 10, 2021	BUY	$68.67 - $84.02 $8,377 - $10,250	122 Added 58.65%	330 $23,000
Q2 2021 Aug 04, 2021	BUY	$79.87 - $87.53 $13,897 - $15,230	174 Added 511.76%	208 $17,000
Q4 2020 Feb 04, 2021	SELL	$80.74 - $97.7 $5,571 - $6,741	-69 Reduced 66.99%	34 $3,000
Q3 2020 Nov 09, 2020	BUY	$85.07 - $109.69 $425 - $548	5 Added 5.1%	103 $9,000
Q2 2020 Aug 06, 2020	BUY	$74.18 - $108.93 $5,340 - $7,842	72 Added 276.92%	98 $10,000
Q1 2020 May 12, 2020	BUY	$63.18 - $85.97 $568 - $773	9 Added 52.94%	26 $2,000
Q4 2019 Feb 07, 2020	BUY	$73.04 - $95.72 $657 - $861	9 Added 112.5%	17 $1,000
Q3 2019 Nov 01, 2019	SELL	$72.82 - $86.52 $218 - $259	-3 Reduced 27.27%	8 $1,000
Q2 2019 Aug 08, 2019	BUY	$73.52 - $88.7 $220 - $266	3 Added 37.5%	11 $1,000
Q4 2018 Feb 06, 2019	BUY	$58.5 - $69.94 $234 - $279	4 Added 100.0%	8 $1,000
Q2 2018 Aug 09, 2018	SELL	$60.85 - $83.98 $1,156 - $1,595	-19 Reduced 82.61%	4 $0
Q1 2018 May 01, 2018	BUY	$83.06 - $100.98 $1,661 - $2,019	20 Added 666.67%	23 $2,000
Q4 2017 Feb 06, 2018	SELL	$93.56 - $116.6 $561 - $699	-6 Reduced 66.67%	3 $0
Q3 2017 Nov 13, 2017	SELL	$109.15 - $138.27 $1,200 - $1,520	-11 Reduced 55.0%	9 $1,000
Q2 2017 Aug 09, 2017	BUY	N/A	20	20 $3,000

Others Institutions Holding INCY

# of Institutions

642

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15.8B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Glassman Wealth Services, based on Form 13F filings with the SEC.

News

Stay updated on Glassman Wealth Services with notifications on news.

Account